(Q35977112)

English

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

based on heuristic

inferred from title

Marina Elena Cazzaniga

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

P Lissoni

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

S Barni

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

G Tancini

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

A Ardizzoia

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

F Rovelli

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

F Brivio

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

A Piperno

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

R Aldeghi

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

D Fossati

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

language of work or name

0 references

publication date

1 June 1993

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

67

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1404-1407

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

https://scigraph.springernature.com/pub.10.1038/bjc.1993.260

0 references

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968531

2 October 2017

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968531

2 October 2017

Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968531

27 July 2018

Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968531

27 July 2018

Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968531

24 September 2018

Effect of melatonin on experimental tumors under different photoperiods and times of administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/8512825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of natural cytotoxicity by beta-endorphin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8512825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine and immune effects of melatonin therapy in metastatic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8512825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8512825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatonin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8512825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/8512825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1993.260

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8512825%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35977112&oldid=1709601182"